Cytomegalovirus retinitis and viral resistance: 3. Culture results

American Journal of Ophthalmology

Volumn 126, Issue 4, 1998, Pages 543-549

  Jabs, Douglas A ^a   Enger, Cheryl ^a   Dunn, J P ^a   Forman, Michael ^a   Hubbard, Larry ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; FOSCARNET; GANCICLOVIR;

ADULT; ARTICLE; BLOOD CULTURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; RETINITIS; URINE CULTURE; VIRUS CULTURE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; BALTIMORE; BLOOD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; CYTOSINE; DRUG RESISTANCE, MICROBIAL; FEMALE; FOLLOW-UP STUDIES; FOSCARNET; GANCICLOVIR; HUMANS; MALE; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; URINE; VIREMIA;

EID: 0032189596     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(98)00134-2     Document Type: Article

References (22)

1. Jabs D.A., Enger C., Bartlett J.G. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 107:1989;75-80.
2. Jabs D.A. Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc. 93:1995;623-683.
3. Pepose J.S., Holland G.N., Nestor M.S., Cochran A.J., Foos R.Y. Acquired immune deficiency syndrome pathogenic mechanisms of ocular disease . Ophthalmology. 92:1985;472-484.
4. Pertel P., Hirschtick R., Phair J., Chmiel J., Poggensee L., Murphy R. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr. 5:1992;1069-1074.
5. Gallant J.E., Moore R.D., Richman D.D., Keruly J., Chaisson R.E. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis. 166:1992;1223-1227.
6. Hoover D.R., Saah A.J., Bacellar H., et al. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N Engl J Med. 329:1993;1922-1926.
7. Hoover D.R., Peng Y., Saah A., et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol. 114:1996;821-827.
8. Spector S.A., Weingeist T., Pollard R.B., et al. A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. J Infect Dis. 168:1993;557-563.
9. Intravenous versus oral ganciclovir European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS . AIDS. 9:1995;471-477.
10. Drew W.L., Ives D., Lalezari J.P., et al. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. N Engl J Med. 333:1995;615-620.
11. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med. 326:1992;213-220.
12. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 4. Visual outcomes. Ophthalmology. 101:1994;1250-1261.
13. Martin D.F., Parks D.J., Mellow S.D., et al. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. Arch Ophthalmol. 112:1994;1531-1539.
14. Palestine A.G., Polis M.A., De Smet M.D., et al. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med. 115:1991;665-673.
15. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS the HPMPC Peripheral Cytomegalovirus Retinitis Trial . Ann Intern Med. 126:1997;264-274.
16. Drew W.L., Miner R.C., Busch D.F., et al. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis. 163:1991;716-719.
17. Dunn J.P., MacCumber M.W., Forman M.S., Charache P., Apuzzo L., Jabs D.A. Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir. Am J Ophthalmol. 119:1995;587-596.
18. Flores-Aguilar M., Kuppermann B.D., Quiceno J.I., et al. Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis. Ophthalmology. 100:1993;1022-1031.
19. Erice A., Chou S., Biron K.K., Stanat S.C., Balfour H.H. Jr, Jordan M.C. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N Engl J Med. 320:1989;289-293.
20. Enger C., Jabs D.A., Dunn J.P., et al. Viral resistance and CMV retinitis design and methods of a prospective study . Ophthalmic Epidemiol. 4:1997;41-48.
21. Jabs DA, Dunn JP, Enger C, Forman M, Bressler N, Charache C, for the Cytomegalovirus Retinitis and Viral Resistance Study Group. Cytomegalovirus retinitis and viral resistance: prevalence of resistance at diagnosis, 1994. Arch Ophthalmol 1996;114:809-814.
22. Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. J Infect Dis. 176:1997;50-58.